Jennifer A. Grabowsky

Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors

Adil Daud, Michelle T. Ashworth, Jonathan Strosberg et al. · Journal of Clinical Oncology · 2015 · 184 citations · Full text

Quantification of Inflammatory Mediators in Stool Samples of Patients with Inflammatory Bowel Disorders and Controls

Stephan C. Bischoff, Jennifer A. Grabowsky, Michael P. Manns · Digestive Diseases and Sciences · 1997 · 100 citations

Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies

Rahul Aggarwal, Scott Thomas, Nela Pawłowska et al. · Journal of Clinical Oncology · 2017 · 99 citations · Full text

Differential Toxicity in Patients with and without DNA Repair Mutations: Phase I Study of Carboplatin and Talazoparib in Advanced Solid Tumors

Mallika Dhawan, Imke H. Bartelink, Rahul Aggarwal et al. · Clinical Cancer Research · 2017 · 76 citations · Full text

A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanced solid tumors or multiple myeloma

Johanna C. Bendell, Robin Kate Kelley, Kent C. Shih et al. · Cancer · 2015 · 75 citations · Full text